LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine

Gastric cancer is the third leading cause of cancer death with 5‐year survival rate of about 30–35%. Since early detection is associated with decreased mortality, identification of novel biomarkers for early diagnosis and proper management of patients with the best response to therapy is urgently needed. Long noncoding RNAs (lncRNAs) due to their high specificity, easy accessibility in a noninvasive manner, as well as their aberrant expression under different pathological and physiological conditions, have received a great attention as potential diagnostic, prognostic, or predictive biomarkers. They may also serve as targets for treating gastric cancer. In this review, we highlighted the role of lncRNAs as tumor suppressors or oncogenes that make them potential biomarkers for the diagnosis and prognosis of gastric cancer. Relatively, lncRNAs such as H19, HOTAIR, UCA1, PVT1, tissue differentiation‐inducing nonprotein coding, and LINC00152 could be potential diagnostic and prognostic markers in patients with gastric cancer. Also, the impact of lncRNAs such as ecCEBPA, MLK7‐AS1, TUG1, HOXA11‐AS, GAPLINC, LEIGC, multidrug resistance‐related and upregulated lncRNA, PVT1 on gastric cancer epigenetic and drug resistance as well as their potential as therapeutic targets for personalized medicine was discussed.

[1]  Xuan Feng,et al.  Effect and mechanism of long noncoding RNAs HOTAIR on occurrence and development of gastric cancer , 2019, Journal of cellular biochemistry.

[2]  S. Fattahi,et al.  DNA methyltransferases and gastric cancer: insight into targeted therapy. , 2018, Epigenomics.

[3]  A. Samadani,et al.  Prevalence of multiple infections and the risk of gastric adenocarcinoma development at earlier age. , 2018, Diagnostic microbiology and infectious disease.

[4]  Hong Zhang,et al.  LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway , 2018, Molecular cancer.

[5]  A. Samadani,et al.  Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections , 2018, Journal of cellular physiology.

[6]  R. Wu,et al.  Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis , 2018, OncoTargets and therapy.

[7]  S. Fattahi,et al.  Infection‐associated epigenetic alterations in gastric cancer: New insight in cancer therapy , 2018, Journal of cellular physiology.

[8]  Zhiguang Sun,et al.  Long noncoding RNA GAPLINC promotes gastric cancer cell proliferation by acting as a molecular sponge of miR-378 to modulate MAPK1 expression , 2018, OncoTargets and therapy.

[9]  Wenfang Zhang,et al.  Knockdown of the lncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastric carcinoma , 2018, Cellular & Molecular Biology Letters.

[10]  Jue Zhang,et al.  Identification of differential expression lncRNAs in gastric cancer using transcriptome sequencing and bioinformatics analyses , 2018, Molecular medicine reports.

[11]  Liesheng Lu,et al.  UCA1 promotes cell proliferation and invasion of gastric cancer by targeting CREB1 sponging to miR‐590‐3p , 2018, Cancer medicine.

[12]  Zhaohua Shen,et al.  Knockdown of long non-coding RNA MAP3K20 antisense RNA 1 inhibits gastric cancer growth through epigenetically regulating miR-375. , 2018, Biochemical and biophysical research communications.

[13]  Y. Dong,et al.  Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway. , 2018, European review for medical and pharmacological sciences.

[14]  Yuanzhen Zheng,et al.  Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  Baiyu Chen,et al.  XIST promotes gastric cancer (GC) progression through TGF‐β1 via targeting miR‐185 , 2018, Journal of cellular biochemistry.

[16]  Y. Zhang,et al.  Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer , 2018, Molecular Cancer.

[17]  Hong Xu,et al.  Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/β-catenin signaling in gastric cancer cells , 2018, Bioscience, biotechnology, and biochemistry.

[18]  Jianjun Wang,et al.  Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a. , 2018, International journal of biological macromolecules.

[19]  Shuyuan Wang,et al.  Systematical analysis of lncRNA–mRNA competing endogenous RNA network in breast cancer subtypes , 2018, Breast Cancer Research and Treatment.

[20]  Jun Liu,et al.  Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer , 2018, Cell Death & Disease.

[21]  Pei Ma,et al.  Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer , 2018, Clinical Cancer Research.

[22]  Hui Luo,et al.  LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation , 2018, Bioscience reports.

[23]  Yunxin Zhang,et al.  LncRNA GACAT3 promotes gastric cancer progression by negatively regulating miR-497 expression. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  Y. Shan,et al.  LINC00052 Promotes Gastric Cancer Cell Proliferation and Metastasis via Activating the Wnt/β-Catenin Signaling Pathway. , 2017, Oncology research.

[25]  Li Feng,et al.  Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway , 2017, Journal of Biosciences.

[26]  Junming Guo,et al.  Regulatory mechanisms of long noncoding RNAs on gene expression in cancers. , 2017, Cancer genetics.

[27]  M. Emadi-Baygi,et al.  Augmented expression levels of lncRNAs ecCEBPA and UCA1 in gastric cancer tissues and their clinical significance , 2017, Iranian journal of basic medical sciences.

[28]  Yang Cao,et al.  LncRNA‐PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis , 2017, EMBO reports.

[29]  Wei Liu,et al.  LncRNA-SNHG1 contributes to gastric cancer cell proliferation by regulating DNMT1. , 2017, Biochemical and biophysical research communications.

[30]  B. Du,et al.  LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells , 2017, Bioscience reports.

[31]  D. Long,et al.  MiR-381 inhibits migration and invasion in human gastric carcinoma through downregulatedting SOX4. , 2017, Oncology letters.

[32]  Yuepu Pu,et al.  Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway , 2017, OncoTarget.

[33]  Ning-Bo Hao,et al.  The role of miRNA and lncRNA in gastric cancer , 2017, Oncotarget.

[34]  L. Ge,et al.  High expression level of long non-coding RNA HOTAIR is associated with poor overall survival in gastric cancer patients: evidence from meta-analysis. , 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[35]  Yuanfang Zhu,et al.  LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p , 2017, Cellular Physiology and Biochemistry.

[36]  Y. Wang,et al.  MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer , 2017, British Journal of Cancer.

[37]  L. Teng,et al.  LncRNA UCA1 in anti-cancer drug resistance , 2017, Oncotarget.

[38]  L. Teng,et al.  LncRNA UCA1 in anti-cancer drug resistance , 2017, Oncotarget.

[39]  E. Zhang,et al.  E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis , 2017, Cell Death & Disease.

[40]  Meijing Zhang,et al.  The novel long noncoding RNA RP11–357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer , 2017, OncoTargets and therapy.

[41]  Guangjian Huang,et al.  Long Noncoding RNA CRNDE Promotes Proliferation of Gastric Cancer Cells by Targeting miR-145 , 2017, Cellular Physiology and Biochemistry.

[42]  Ming Sun,et al.  Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer , 2017, Molecular Cancer.

[43]  Jing-hua Zhang,et al.  Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297 , 2017, Cancer Cell International.

[44]  Ming Sun,et al.  Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[45]  S. Gray,et al.  Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells , 2017, Cancers.

[46]  Zhongyong Zhou,et al.  Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[47]  Lei Ding,et al.  MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2 , 2017, Journal of experimental & clinical cancer research : CR.

[48]  Jianwen Liu,et al.  Lnc-ATB contributes to gastric cancer growth through a MiR-141-3p/TGFβ2 feedback loop. , 2017, Biochemical and biophysical research communications.

[49]  Xiang-ling Meng,et al.  Long Noncoding RNA PVT1 Acts as a “Sponge” to Inhibit microRNA-152 in Gastric Cancer Cells , 2017, Digestive Diseases and Sciences.

[50]  Lili Liu,et al.  The role of MALAT-1 in the invasion and metastasis of gastric cancer , 2017, Scandinavian journal of gastroenterology.

[51]  Pengji Gao,et al.  Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer , 2017, OncoTargets and therapy.

[52]  Yao Lei,et al.  Correction: Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer , 2017, Oncotarget.

[53]  Q. Xue,et al.  Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer , 2017, Oncotarget.

[54]  Jun Yu,et al.  The Interplay of LncRNA-H19 and Its Binding Partners in Physiological Process and Gastric Carcinogenesis , 2017, International journal of molecular sciences.

[55]  Kecheng Zhang,et al.  Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer , 2017, Theranostics.

[56]  L. Hua,et al.  Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer , 2016, Oncotarget.

[57]  Xiaojun Luo,et al.  Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer , 2016, Oncotarget.

[58]  C. Braconi,et al.  Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know? , 2016, Future oncology.

[59]  Guoxin Zhang,et al.  Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c , 2016, Oncotarget.

[60]  Hejun Zhang,et al.  SNHG8 is identified as a key regulator of epstein-barr virus(EBV)-associated gastric cancer by an integrative analysis of lncRNA and mRNA expression , 2016, Oncotarget.

[61]  Ming Sun,et al.  LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1. , 2016, Cancer research.

[62]  Liang Zhao,et al.  Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets , 2016, World journal of gastroenterology.

[63]  Shanshan Liu,et al.  DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis , 2016, EBioMedicine.

[64]  Xiaoyan Chen,et al.  Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[65]  Wanqing Chen,et al.  Helicobacter pylori infection, H19 and LINC00152 expression in serum and risk of gastric cancer in a Chinese population. , 2016, Cancer epidemiology.

[66]  Wenhuan Li,et al.  IL-8 interacts with metadherin promoting proliferation and migration in gastric cancer. , 2016, Biochemical and biophysical research communications.

[67]  Y. Xi,et al.  Novel long non-coding RNA GACAT3 promotes gastric cancer cell proliferation through the IL-6/STAT3 signaling pathway , 2016, Tumor Biology.

[68]  Fenghua Wang,et al.  Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression , 2016, Journal of Experimental & Clinical Cancer Research.

[69]  P. Li,et al.  Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway. , 2016, American journal of translational research.

[70]  Yingyan Yu,et al.  MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer , 2016, PloS one.

[71]  Ming Liu,et al.  The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis , 2016, Oncotarget.

[72]  F. He,et al.  Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer , 2016, Oncogene.

[73]  Tian-Tian Sun,et al.  LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern. , 2016, Cancer discovery.

[74]  N. Zhang,et al.  GAS5 is downregulated in gastric cancer cells by promoter hypermethylation and regulates adriamycin sensitivity. , 2016, European review for medical and pharmacological sciences.

[75]  Xia Han,et al.  Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells. , 2016, Oncology reports.

[76]  Jie Yuan,et al.  Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer , 2016, Oncotarget.

[77]  Lin Fan,et al.  HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression. , 2016, Oncology reports.

[78]  Junming Guo,et al.  Roles of long noncoding RNAs in gastric cancer and their clinical applications , 2016, Journal of Cancer Research and Clinical Oncology.

[79]  Ming Sun,et al.  Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression , 2016, Oncotarget.

[80]  Xiangjian Chen,et al.  The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer , 2016, Scientific Reports.

[81]  Y. Shao,et al.  LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer , 2016, Oncotarget.

[82]  Jie Xu,et al.  Roles of competing endogenous RNAs in gastric cancer. , 2016, Briefings in functional genomics.

[83]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[84]  T. Shi,et al.  Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics , 2016, Disease markers.

[85]  Yan Guo,et al.  Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer , 2016, Cancer Chemotherapy and Pharmacology.

[86]  Kun Liu,et al.  Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts poor prognosis in gastric cancer , 2016, OncoTargets and therapy.

[87]  Xixun Wang,et al.  Silencing of LncRNA HULC Enhances Chemotherapy Induced Apoptosis in Human Gastric Cancer , 2016, Journal of medical biochemistry.

[88]  Zhongtao Zhang,et al.  TET2 regulates LncRNA‐ANRIL expression and inhibits the growth of human gastric cancer cells , 2016, IUBMB life.

[89]  P. Gao,et al.  A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion , 2016, Journal of Cancer Research and Clinical Oncology.

[90]  Gao Liu,et al.  Long Noncoding RNA H19-Derived miR-675 Enhances Proliferation and Invasion via RUNX1 in Gastric Cancer Cells , 2016, Oncology research.

[91]  賢治 高橋,et al.  膵癌とlong non-coding RNA , 2016 .

[92]  Ping Chen,et al.  Long noncoding RNAs in gastric cancer: functions and clinical applications , 2016, OncoTargets and therapy.

[93]  H. Ooi,et al.  MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10 , 2016, Oncotarget.

[94]  E. Zhang,et al.  Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57 , 2016, Cell Death and Disease.

[95]  R. Kong,et al.  Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer , 2016, Oncotarget.

[96]  B. Xiao,et al.  Molecular mechanisms of long noncoding RNAs on gastric cancer , 2016, Oncotarget.

[97]  Ping Zheng,et al.  Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer. , 2016, Biochimica et biophysica acta.

[98]  E. Zhang,et al.  E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs , 2015, Oncotarget.

[99]  Qiang Wang,et al.  Microarray analysis of Long non-coding RNA expression profiles in human gastric cells and tissues with Helicobacter pylori Infection , 2015, BMC Medical Genomics.

[100]  L. Dai,et al.  Competing endogenous RNA networks and gastric cancer. , 2015, World journal of gastroenterology.

[101]  X. Zhi,et al.  Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway , 2015, Journal of experimental & clinical cancer research : CR.

[102]  Lei Ding,et al.  Dysregulation of non-coding RNAs in gastric cancer. , 2015, World journal of gastroenterology.

[103]  M. Gorospe,et al.  Long noncoding RNA turnover. , 2015, Biochimie.

[104]  Xinyang Lu,et al.  BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-κB1. , 2015, Biochemical and biophysical research communications.

[105]  Kexin Wang,et al.  Long non-coding RNA HOTAIR promotes HLA-G expression via inhibiting miR-152 in gastric cancer cells. , 2015, Biochemical and biophysical research communications.

[106]  Tianxiang Chen,et al.  LncRNAs: emerging biomarkers in gastric cancer. , 2015, Future oncology.

[107]  F. Wang,et al.  Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression , 2015, Journal of experimental & clinical cancer research : CR.

[108]  J. Zhao,et al.  Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer , 2015, Cell cycle.

[109]  P. Bu,et al.  Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. , 2015, Biochemical and biophysical research communications.

[110]  E. Zhang,et al.  LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer , 2015, Cell Death and Disease.

[111]  Guoxin Zhang,et al.  The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer , 2015, Cellular Physiology and Biochemistry.

[112]  Xiaoqiang Guo,et al.  GAS5 Inhibits Gastric Cancer Cell Proliferation Partly by Modulating CDK6 , 2015, Oncology Research and Treatment.

[113]  Yanhong Zhu,et al.  MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2 , 2015, PloS one.

[114]  Xinshu Xiao,et al.  Noncoding RNAs in human saliva as potential disease biomarkers , 2015, Front. Genet..

[115]  Lei Zhang,et al.  Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[116]  A. Scorilas,et al.  Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? , 2015, Gastroenterology research and practice.

[117]  Ming Sun,et al.  Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16 , 2015, Molecular Cancer.

[118]  Mu-Kuan Chen,et al.  Transcriptional regulation of Mcl-1 plays an important role of cellular protective effector of vincristine-triggered autophagy in oral cancer cells , 2015, Expert opinion on therapeutic targets.

[119]  R. Kong,et al.  SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer , 2015, Oncogene.

[120]  Zuqiang Liu,et al.  Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer , 2015, Drug design, development and therapy.

[121]  Jia Xu,et al.  HOTAIR Long Noncoding RNA Promotes Gastric Cancer Metastasis through Suppression of Poly r(C)-Binding Protein (PCBP) 1 , 2015, Molecular Cancer Therapeutics.

[122]  S. Dhanasekaran,et al.  The landscape of long noncoding RNAs in the human transcriptome , 2015, Nature Genetics.

[123]  Jian Huang,et al.  LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition , 2014, BMC Cancer.

[124]  Jie Xu,et al.  Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. , 2014, Cancer research.

[125]  Hongwei Zhang,et al.  Hypoxia-Inducible lncRNA-AK058003 Promotes Gastric Cancer Metastasis by Targeting γ-Synuclein , 2014, Neoplasia.

[126]  Bing‐Xia Zhou,et al.  Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer. , 2014, International journal of clinical and experimental pathology.

[127]  Dan Li,et al.  Oncotargets and Therapy Dovepress Expression and Clinical Significance of the Long Non-coding Rna Pvt1 in Human Gastric Cancer , 2022 .

[128]  Ming Sun,et al.  Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression , 2014, Journal of Hematology & Oncology.

[129]  Yongzhan Nie,et al.  Long Noncoding RNA MRUL Promotes ABCB1 Expression in Multidrug-Resistant Gastric Cancer Cell Sublines , 2014, Molecular and Cellular Biology.

[130]  Shaoli Das,et al.  lnCeDB: Database of Human Long Noncoding RNA Acting as Competing Endogenous RNA , 2014, PloS one.

[131]  Ping Wang,et al.  The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. , 2014, Biochemical and biophysical research communications.

[132]  M. Emadi-Baygi,et al.  Association of HOTAIR expression in gastric carcinoma with invasion and distant metastasis , 2014, Advanced biomedical research.

[133]  Ming Sun,et al.  Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer , 2014, BMC Cancer.

[134]  K. Morris,et al.  The rise of regulatory RNA , 2014, Nature Reviews Genetics.

[135]  Ming Sun,et al.  Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer , 2014, Molecular Cancer.

[136]  Zhenggang Zhu,et al.  Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer , 2014, Oncotarget.

[137]  Ming Sun,et al.  Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a , 2014, Oncotarget.

[138]  R. Kong,et al.  c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer , 2014, Medical Oncology.

[139]  T. Xia,et al.  Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance , 2014, Tumor Biology.

[140]  Xiaoqiang Guo,et al.  MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1 , 2014, Medical Oncology.

[141]  Feng Yang,et al.  Long non‐coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c‐Myc mRNA stability , 2014, The FEBS journal.

[142]  Rui Xia,et al.  Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer , 2014, Tumor Biology.

[143]  N. Tanaka,et al.  Enhanced Expression of Long Non-Coding RNA HOTAIR Is Associated with the Development of Gastric Cancer , 2013, PloS one.

[144]  Xuefei Shi,et al.  Long non-coding RNAs: a new frontier in the study of human diseases. , 2013, Cancer letters.

[145]  Pu Zhang,et al.  DNMT1-interacting RNAs block gene specific DNA methylation , 2013, Nature.

[146]  Li-tao Yang,et al.  Knockdown of Long Non-coding RNA HOTAIR Suppresses Tumor Invasion and Reverses Epithelial-mesenchymal Transition in Gastric Cancer , 2013, International journal of biological sciences.

[147]  Jeannie T. Lee,et al.  Long Noncoding RNAs: Past, Present, and Future , 2013, Genetics.

[148]  Feng Yang,et al.  Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma , 2013, Journal of Cancer Research and Clinical Oncology.

[149]  Feng Yang,et al.  Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells , 2012, The FEBS journal.

[150]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[151]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[152]  M. Kitagawa,et al.  Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor gene , 2011, Oncogene.

[153]  M. Allday,et al.  Epigenetic reprogramming of host genes in viral and microbial pathogenesis , 2010, Trends in microbiology.

[154]  B. Davies,et al.  BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. , 2010, Current opinion in molecular therapeutics.

[155]  Steven Hahn,et al.  Transcriptional regulation Meeting on Regulatory Mechanisms in Eukaryotic Transcription , 2008 .

[156]  Jing Chen,et al.  Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death , 2008, International journal of cancer.

[157]  D. Fan,et al.  Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges , 2007, Expert review of anticancer therapy.

[158]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[159]  Dominic P. Norris,et al.  The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus , 1992, Cell.

[160]  C. Stevens,et al.  Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis , 2021, Nature Reviews Neuroscience.

[161]  E. Dees,et al.  The product of the H19 gene may function as an RNA , 1990, Molecular and cellular biology.

[162]  Jongchan Kim,et al.  Long noncoding RNA , 2019 .

[163]  Zhiguang Sun,et al.  long noncoding rna gaPlinc promotes gastric cancer cell proliferation by acting as a molecular sponge of mir-378 to modulate MaPK 1 expression , 2018 .

[164]  M. Esteller,et al.  lncRNAs and microRNAs with a role in cancer development. , 2016, Biochimica et biophysica acta.

[165]  Y F Wang,et al.  H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. , 2016, Neoplasma.

[166]  Xiang Li,et al.  Long non-coding RNA CCAT1 that can be activated by c-Myc promotes pancreatic cancer cell proliferation and migration. , 2016, American journal of translational research.

[167]  Qing,et al.  MALAT 1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH 10 , 2016 .

[168]  Peng Li,et al.  Long non-coding RNA CASC 2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway , 2016 .

[169]  Yi Huang,et al.  Long noncoding RNA linc-UBC1 is negative prognostic factor and exhibits tumor pro-oncogenic activity in gastric cancer. , 2015, International journal of clinical and experimental pathology.

[170]  Qingyang,et al.  Dysregulation of non-coding RNAs in gastric cancer , 2015 .

[171]  R. Kurokawa,et al.  Long Noncoding RNAs , 2015, Springer Japan.

[172]  Yan Zhao,et al.  Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. , 2014, Oncology reports.

[173]  Jie Xu,et al.  Long Noncoding RNA GAPLINC Regulates CD 44-Dependent Cell Invasiveness and Associates with Poor Prognosis of Gastric Cancer , 2014 .

[174]  Dan Li,et al.  Expression and clinical significance of the long non-coding rna PVT 1 in human gastric cancer , 2014 .

[175]  Wei Liu,et al.  LncRNA-SNHG 1 contributes to gastric cancer cell proliferation by regulating DNMT 1 , 2022 .